Zinc Gluconate

产品说明书

Print
Chemical Structure| 4468-02-4 同义名 : 葡萄糖酸锌 水合物 ;Zinc gluconate hydrate
CAS号 : 4468-02-4
货号 : A536852
分子式 : C12H22O14Zn
纯度 : 98%
分子量 : 455.7
MDL号 : MFCD00868110
存储条件:

Pure form Inert atmosphere, room temperature

In solvent -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 50 mg/mL(109.72 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 50 mg/mL(109.72 mM),配合低频超声助溶

生物活性
描述 Zinc gluconate may be a PPAR-α (Peroxisome proliferator-activated receptors-α) agonist. Zinc gluconate is efficient in the treatment of several inflammatory dermatoses. In inflammatory LPS-stimulated explants, zinc gluconate significantly upregulated PPAR-α function and mRNA expression level, without changing its epidermal protein expression[1]. Treatment with sage oil (0.042mg/kg IP) and Zinc gluconate orally (150mg/kg) body weight daily for 8 weeks significantly reduced serum glucose, C-reactive protein (CRP), Tumor necrosis factor alpha (TNF- α), interleukins-6 1 β, inflammatory8 (IFN ȣ), pancreatic 1L1-β along with an increase in serum Zinc and pancreatic Zinc transporter 8 (ZNT8)[2]. Zinc gluconate intervention in patients with ulcerative colitis improves the nutritional status of this mineral in these patients and positively influences their clinical outcome, reinforcing the role of zinc as an important dietary component in disease control[3]. Zinc absorption in humans could be improved by zinc complexation with gluconate[4].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.97mL

2.19mL

1.10mL

21.94mL

4.39mL

2.19mL

参考文献

[1]Poiraud C, Quereux G, Knol AC, Allix R, Khammari A, Dreno B. Zinc gluconate is an agonist of peroxisome proliferator-activated receptor-α in the epidermis. Exp Dermatol. 2012 May;21(5):347-51

[2]Elseweidy MM, Ali AA, Elabidine NZ, Mursey NM. Effect of zinc gluconate, sage oil on inflammatory patterns and hyperglycemia in zinc deficient diabetic rats. Biomed Pharmacother. 2017 Nov;95:317-323

[3]de Moura MSB, Soares NRM, Barros SÉL, de Pinho FA, Silva TMC, Bráz DC, Vieira EC, Lima MM, Parente JML, Marreiro DDN, da Silva AS, Nogueira NDN. Zinc gluconate supplementation impacts the clinical improvement in patients with ulcerative colitis. Biometals. 2020 Feb;33(1):15-27

[4]Siepmann M, Spank S, Kluge A, Schappach A, Kirch W. The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men. Int J Clin Pharmacol Ther. 2005 Dec;43(12):562-5